The Trump Administration’s Attempts to Ban Gender Affirming Care for Minors Are Illegal, by Sean M. McBride and Alexander Chen
On Dec. 18, 2025 the U.S. Department of Health and Human Services issued a proposed rule that would make gender‑affirming care for minors a condition of participation in Medicare and Medicaid. If finalized, hospitals that continue offering such care could lose federal reimbursements, threatening their financial viability. The rule relies on broad language in the Social Security Act, but legal analysts argue it conflicts with Section 1801’s ban on federal control of medical practice, Medicaid’s EPSDT mandate, and the Administrative Procedure Act. Courts are expected to hear challenges that could limit the federal government’s ability to dictate specific treatments.
When Is a High Readmission Patient Also a Happier Patient?
A retrospective cohort of 66 ankylosing spondylitis or DISH patients matched to 198 controls examined outcomes after elective cervical and lumbar fusion. After adjusting for comorbidities, the AS/DISH group was six times more likely to be readmitted within 30 days....
Leading Scots Audiology Group The Hearing Clinic UK Expands Into England
The Hearing Clinic UK, a Glasgow‑based audiology group, announced the acquisition of the award‑winning Congleton Hearing Centre in Cheshire, marking its first expansion into England. The deal follows a record 2025 in which the group served more than 7,000 patients....
How Rare Earths Enabled MRI Contrast Agents to Advance Medical Imaging
MRI contrast agents, primarily based on the rare‑earth element gadolinium, have revolutionized diagnostic imaging by highlighting blood flow, blood‑brain barrier disruption, and active disease. By chelating gadolinium into macrocyclic or linear compounds, manufacturers make the metal safe for intravenous use...
How I Help Patients Safely Get Off Medications They No Longer Need
Psychiatrist Jake Goodman outlines his deprescribing framework, showing how he safely tapers patients off long‑term benzodiazepines, Z‑drugs, and over‑the‑counter sleep aids. Using a compounding pharmacy, he creates micro‑dose reductions to avoid withdrawal seizures, rebound anxiety, and cognitive fog. He stresses...
4 Questions to Ask About Enterprise AI Drug Dosing
Artificial intelligence is entering the most sensitive clinical workflow—drug dosing—through two divergent paths. In clinician‑driven adoption, tools appear organically but often lack standardization and oversight, while enterprise‑level deployments embed AI within governed workflows, offering traceability and consistency. Health systems are...
(Equal Weight) Biotech Earnings Estimates/Revisions
The Equal‑Weighted Biotech ETF (XBI)’s top 30 holdings saw a sharp pull‑back in earnings forecasts over the past 60 days. 2026 earnings power was cut by 64.30%, while 2027 estimates fell 24.36%. The revision tally shows more downside than upside,...
How Corporate Health Care Ruined the Medical Profession
The article argues that corporate health‑care systems have replaced community‑driven, often religious, hospital boards with profit‑focused executives, eroding the profession’s traditional values. It details how boards are now staffed by CEOs, CFOs and lawyers whose primary goal is shareholder return,...
The MolinaCares Accord Provides $100,000 Grant to Lurie Children’s in Support of Statewide School Mental Health Initiative
MolinaCares, the community‑investment arm of Molina Healthcare, has awarded a $100,000 grant to Lurie Children’s Hospital’s Center for Childhood Resilience to support the Resilience‑Supportive Schools Illinois (RSSI) initiative. RSSI equips Illinois schools with data‑driven tools, professional learning, and evidence‑informed resources...
Samsung Bioepis Releases Second Quarter 2026 US Biosimilar Market Report
Samsung Bioepis released its Q2 2026 U.S. Biosimilar Market Report, the thirteenth edition of the quarterly series. The report documents 92 FDA‑approved biosimilars across 20 molecules, with 67 (73 %) already launched, and notes a 60 % adoption rate for adalimumab biosimilars. It...
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
Cerus Corporation announced a four‑year supply agreement with France’s national blood service, Établissement Français du Sang (EFS), for its INTERCEPT Blood System covering platelets, plasma, and the new LED‑based INT200 illumination device. EFS distributes roughly 330,000 platelet units each year...
GDC-4198
Regor Therapeutics discovered GDC‑4198, an oral CDK4/2 inhibitor now owned by Genentech. The drug is in Phase 1/2 trials for advanced solid tumors, with a focus on breast cancer. It combines low‑nanomolar CDK4 potency with comparable CDK2 activity and roughly 20‑fold...
Mundipharma Announces Positive Topline Results From Phase III ReSPECT Trial Assessing ▼REZZAYO® (Rezafungin) for the Prophylaxis of Invasive Fungal Diseases...
Mundipharma reported that its Phase III ReSPECT trial met the primary endpoint, showing rezafungin (REZZAYO®) was non‑inferior to standard antifungal regimens for fungal‑free survival at Day 90 (60.7% vs 59.0%). The once‑weekly echinocandin demonstrated a comparable safety profile with fewer drug‑drug interactions...
Judy Gets Her Freakonomics On
Freakonomics recently interviewed Epic Systems CEO Judy Faulkner, during which she highlighted Epic’s claim of offering more APIs than any other EHR vendor. Faulkner explained that data access requires permission from the individual health organization, positioning Epic as a neutral...
Ligand Pharmaceuticals Acquires XOMA Royalty in a $739 Million Deal
Ligand Pharmaceuticals announced a $739 million acquisition of XOMA Royalty Corporation, offering $39 per share—a 2.9% premium to the prior close. The transaction also grants XOMA shareholders a contingent value right (CVR) tied to 75% of net proceeds from pending TREMFYA...
VVARDIS Announces Investment From Apollo —Achieves Unicorn Status
vVARDIS Holding AG announced a strategic minority investment from Apollo‑managed funds, propelling the Swiss dental‑med tech firm into unicorn status with a valuation north of $1 billion. The capital will finance the next phase of global commercial expansion for its Curodont™...
What’s the Data on Delayed Cord Clamping?
Delayed cord clamping (DCC) is now endorsed by ACOG, recommending a 30‑60‑second wait before cutting the umbilical cord for virtually all newborns. In preterm infants, a 2023 Lancet meta‑analysis of about 3,000 babies found DCC cuts mortality by roughly 30%,...
Fragments vs DsbA: Towards a Chemical Probe
Researchers targeting the bacterial oxidoreductase DsbA—a key virulence factor—have advanced fragment‑based efforts toward a chemical probe. Initial screens identified fragments binding a shallow groove and a hidden cryptic pocket, but affinities were modest (~150 µM). By designing molecules that extend beyond...
Molina Q1 2026
Molina Healthcare posted Q1 2026 adjusted earnings per share of $2.35, topping the $2.17 consensus estimate, while operating cash flow reached $1.1 billion. All three segment medical cost ratios (MCRs) beat full‑year guidance, yet management kept the full‑year EPS target at...
Post-COVID Sleep Disturbance: The Microvascular Connection
Recent studies reveal that over 75% of COVID‑19 survivors develop insomnia, a rate far exceeding the 10‑20% seen in the general population. Parallel research in cerebral small vessel disease (CSVD) shows a similar triad of poor sleep, depression, and anxiety,...
The Vaccine Safety Signal the Media Still Won’t Read
A peer‑reviewed paper by Joseph Fraiman and colleagues identified a serious‑adverse‑event signal in the Pfizer and Moderna mRNA Covid‑19 vaccine trials, showing harm‑to‑benefit ratios of roughly 4.4 : 1 for Pfizer and 2.4 : 1 for Moderna. The BBC’s *Everything Is Fake and Nobody...
TriFetch Comes Out of Stealth to Automate the Administrative Work that Slows Specialty Clinics
TriFetch announced a $1.9 million pre‑seed round led by Nexus Venture Partners to commercialize its AI‑driven automation platform for independent specialty clinics. The solution automates patient calls, referral routing, and prior‑authorization workflows, integrating directly with existing clinic systems without requiring EHR...
Rapamycin and Psoriasis
Rapamycin, an mTOR inhibitor used for longevity, is being discussed as a possible psoriasis treatment. The forum post highlights oral versus topical administration, noting early positive skin‑aging results for topical use but no definitive clinical evidence for psoriasis clearance. Users...
Bariatric Surgery Vs. Semaglutides Vs. Endoscopic Visceral Lipectomy
The article contrasts traditional bariatric surgery, GLP‑1 drug semaglutide, and the nascent endoscopic visceral lipectomy (EVL) as obesity interventions. It highlights semaglutide’s high cost, injection regimen, and 35‑50% one‑year discontinuation rate, while noting bariatric surgery’s nutritional risks and weight‑loss plateaus....
NICE Launches Consultation on New Topic Prioritisation Framework
NICE has opened a consultation to overhaul its topic prioritisation manual, aligning it more closely with NHS priorities and national policy. The proposed changes introduce clearer priority definitions, merge the two‑stage framework into a single streamlined process, and adopt a...
How Can Pharma Prices Be Reduced for Americans Without Impacting Innovation?
President Trump announced a sweeping plan to impose 100% tariffs on branded pharmaceuticals, while offering exemptions to companies that sign most‑favored‑nation (MFN) agreements. The policy is framed as a way to force lower drug prices for American patients and to...
The WHO Is Building a Supranational Vaccine Authorization Mechanism
The World Health Organization’s Emergency Use Listing (EUL) has evolved from a temporary pandemic tool into a supranational framework that can shape national vaccine approvals. Israel’s Ministry of Health used the EUL to fast‑track the nOPV2 polio vaccine, effectively allowing...
Article Intro - Open-H to Support Foundation Models in Surgical Robotics
The Open-H-Embodiment Consortium, coordinated by NVIDIA and Johns Hopkins, released the largest open dataset of medical‑robotic video paired with synchronized kinematics. Spanning more than 49 institutions and six robot platforms—including da Vinci, Versius, and MIRA—the collection covers surgical manipulation, ultrasound, and...
What Your CD3 T Cell Engager Is Missing
CD3 T‑cell engagers have become a cornerstone of bispecific immunotherapy, linking T cells to cancer cells via the CD3 receptor. The article argues that despite their success, these molecules often provide only the primary activation signal, neglecting a critical secondary...
The Cure for Death Means Billionaires Will Live Forever—And Be Rich Forever
U.S. billionaires enjoy a dramatically higher life expectancy, with 20% living past 80 compared to just 3.8% of the general population. Their longevity stems from access to premium healthcare, personal trainers, and cutting‑edge nutrition. Meanwhile, leaders like Putin and Xi...
Back to the Vax — Is the Measles Surge Testing MAHA’s Vaccine Rejectionism?
Measles cases in the United States have surged to levels not seen in decades, with the CDC reporting 1,748 infections by April 17, 2026—likely an undercount. The spike has prompted a noticeable shift among some vaccine‑hesitant parents, especially followers of...
Free Radicals Podcast (Longevity / Biotech Oriented)
Kexin Huang, the a16z‑backed founder of Pho, argues that biology is entering an "Agentic Biology" era where AI agents orchestrate research rather than merely analyze data. His Integrated Biology Environment (IBE), embodied in the Biomni platform, acts like an IDE...
Free Radicals Podcast (Longevity / Biotech Oriented)
Nathan Cheng argues that aging remains untreated due to a coordination failure rooted in cultural "deathism," despite roughly 100,000 daily deaths from age‑related diseases. He highlights a stark $5 B versus $100 B+ funding gap between longevity and cancer research, underscoring the...
427. DMSO HEALS THE BRAIN AND NERVOUS SYSTEM
A comprehensive review of dimethyl sulfoxide (DMSO) highlights its neuroprotective mechanisms, including radical scavenging, cerebral blood‑flow enhancement, and reversible blood‑brain barrier opening. Epidemiological data show a ten‑fold lower risk of young‑onset Parkinson’s disease among DMSO users, while clinical observations report...
A Free Red Bead Game Simulator: Try Dr. Deming’s Experiment Online
Mark Graban has launched a free browser‑based Red Bead Game simulator that recreates Dr. W. Edwards Deming’s classic experiment on statistical noise. The tool lets users drag a paddle through a bead box, records 24 draws, and automatically produces a...
Rapid Nanofiber Spinning Fills the Gap in Small-Diameter Vascular Grafts
Researchers at Harvard have demonstrated a focused rotary jet spinning (FRJS) process that fabricates custom small‑diameter vascular grafts in minutes. The technique produces nanofiber scaffolds with tunable architecture, achieving 0.5 mm inner‑diameter tubes in under 90 seconds and larger 10 mm grafts...
Impact of World Ageing Festival Singapore 2026
The World Ageing Festival Singapore 2026, organized by Singapore Management University, convened policymakers, healthcare innovators, and senior‑care providers under the theme “Embracing Longevity: Asia’s Priority, The World’s Opportunity.” The three‑day event attracted thousands of participants and hundreds of exhibitors from...
The Hidden Costs of Delayed Diagnosis and Diagnostic Ambiguity
Healthcare systems routinely accept delayed diagnosis and diagnostic ambiguity, but the hidden costs extend far beyond missed treatment windows. Prolonged uncertainty fuels patient stress, depression, and loss of trust, while repeated misdirected referrals inflate expenses and compound clinical complexity. Administrative...
Why Those Outside Healthcare Control Its Future
The article argues that external forces—big‑tech, finance, employers, and regulators—are reshaping the U.S. health system faster than traditional insiders can adapt. It highlights how AI tools, private capital, and shifting public expectations are driving cost‑cutting and transparency initiatives. Recent data...
RFK Jr. Blasts "Abhorrent" Assisted Suicide: "We Can't Be A Moral Society If America Follows"
Health and Human Services Secretary Robert F. Kennedy Jr. warned U.S. lawmakers that Canada’s expanding assisted‑suicide program, known as Medical Assistance in Dying (MAID), is now the leading cause of death in the country. He cited figures showing Canada on...
😷New Chapter 11 Bankruptcy Filing - John Fitzgibbon Memorial Hospital Inc.😷
On April 21, 2026, John Fitzgibbon Memorial Hospital Inc. and its affiliate Fitzgibbon Health Services filed Chapter 11 bankruptcy in the Western District of Missouri. The hospital operates a 60‑bed acute‑care facility, while FHS runs the 99‑bed The Living Center...
This Week: Gene Editing Babies-Life Saving Science or Risky Business?
The debate over human germline editing intensified as two startups, Manhattan Genomics and Bootstrap Bio, folded after months of scrutiny, while Preventive announced a $30 million funding round backed by Coinbase CEO Brian Armstrong and OpenAI CEO Sam Altman. The controversy...
Scientific Superintelligence: The Deep Blue Moment
In 2026 AI systems are autonomously executing the full scientific method, from hypothesis generation to experimental iteration, at machine speed. Lila Sciences, backed by Flagship Pioneering, has built the first AI‑driven "Science Factories" that operate across biology, chemistry, materials and...
Navigating Medical Training and Residency as a Female Plastic Surgeon
Dr. Smita Ramanadham reflects on her journey as the sole woman in a plastic surgery residency, emphasizing the pivotal role of male mentors and the absence of female role models. She highlights a systemic gap in training that overlooks billing,...
Flickstop
Flickstop’s latest post showcases a chart ranking the top ten surgical robots worldwide for 2026, detailing each system’s rank, country of origin, manufacturer, and specialty. Earlier entries highlight a pandemic‑response robot designed for material handling, disinfection, temperature checks, and patrol...
British Researcher Exposes Fake Autism diagnosis...and Nobody Realizes It
British researcher Dame Uta Frith warned that autism diagnosis relies on behavioral criteria because no objective biomarker exists, making the process partly social. A blog post amplified her comments, suggesting the lack of a test applies to all mental disorders...
Where Commercial VBC Actually Lives Now
Commercial value‑based care (VBC) has moved from theory to operational reality, closing the long‑standing gap with Medicare. Primary‑source data from insurers such as Cigna, Elevance and Blue Shield show measurable cost reductions and improved outcomes in employer‑sponsored plans. The commercial VBC...
Why Cooking for Better Health Makes Dietary Changes Easier
The article argues that home cooking empowers patients to adopt healthier diets, especially by reducing sodium, because it provides tangible, visual cues that reinforce nutritional awareness. It draws on a personal story of a mother with hypertension and explains how...
Commercial Value-Based Care Has Quietly Turned Into a Real Messy, Multi-Payer Operating Layer Wedged Btwn Employer Cost Pressure, Payer Network...
Commercial value‑based care (VBC) has moved from theory to large‑scale operations, but its supporting infrastructure lags a decade behind Medicare. Major payers such as Cigna, Elevance, Blue Shield of California and Blue Cross NC now run hundreds of contracts covering...
Growing Signs That MAHA May Be Losing Momentum
The Movement for Authentic Health Advocacy (MAHA) surged in 2024, promising radical health‑policy reforms and attracting anti‑establishment voters. Recent reports show the Trump administration curbing Robert F. Kennedy Jr.'s influence, while New York Times surveys reveal growing voter disillusion as promised changes stall. Anti‑vaccine rhetoric...